Global Age-Related Macular Degeneration (AMD) Market Research Report 2022-2030

Report Summary

The Age-Related Macular Degeneration (AMD) Market research report provides an in-depth analysis of the currents trends, latest expansions, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2015 and 2021 and also provides the forecast data from year 2022 to 2030 which is based on revenue (USD Million). With the help of all these information research report helps the market contributors to improve market positions. With the help of all these insights Age-Related Macular Degeneration (AMD) Market research report recommends a business strategy for present market participants to strengthen their position in the market.
According to the report, the Age-Related Macular Degeneration (AMD) Market size was USD xx million and it is expected to reach USD xx million by the end of 2030, with a CAGR of xx% during 2022-2030.

Age-related Macular Degeneration (AMD) is the leading cause of blindness in elderly patients in developed communities. It is an eye disease of elderly individuals that causes a progressive loss of the central vision needed to drive, read, recognize faces, and see the world in color. AMD's progression leads to loss of central vision, leaving many patients unable to read, write, or recognize both color and detail, thus compromising the quality of life.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Age-Related Macular Degeneration (AMD) Market along with their effects over the forecast period.

Global Age-Related Macular Degeneration (AMD) Market Segmentation:
By Type:
•	Wet AMD
•	Dry AMD

By Application:
•	Hospital Pharmacies
•	Retail Pharmacies
•	Online Pharmacies

Major Key Players for Global Age-Related Macular Degeneration (AMD) Market:
Acucela Inc., Alimera Sciences Inc., ALLERGAN, Bausch & Lomb Incorporated, Bayer AG, F. Hoffmann La Roche, GlaxoSmithKline PLC, Novartis AG, Ophthotech Corporation, Pfizer Inc, Regeneron Pharmaceuticals, Rxi Pharmaceuticals Inc., Santen Pharmaceuticals Co., and Valeant Pharmaceuticals International, Inc.

Global Age-Related Macular Degeneration (AMD) Market Segmentation by Regions:
In regional analysis, Age-Related Macular Degeneration (AMD) Market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Age-Related Macular Degeneration (AMD) Market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

Important Points Covered by Report:
To analyze the value of the Age-Related Macular Degeneration (AMD) Market, according to the key region.
To study the Age-Related Macular Degeneration (AMD) Market current trends, prospects and also their participation in the entire sector.
Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
Report provides the detailed information about drivers, restraints and future scope of Age-Related Macular Degeneration (AMD) Market.
Report covers the information about historic data analysis as well as forecast period analysis.

Table of content

Table of Contents
Table of Contents

1.    Preface
        1.1.    Report Scope and Description
        1.2.    Research Methodology
                1.2.1.    Phase I-Secondary Research
                1.2.2.    Phase II-Primary Research
                1.2.3.    Phase II-Expert Panel Review
                1.2.4.    Assumptions
                1.2.5.    Approach Adopted

2.    Executive Summary
        2.1.    Global Age-Related Macular Degeneration (AMD) Market Snapshot
                2.1.1.    Global Age-Related Macular Degeneration (AMD) Market, By Type, 2021
                2.1.2.    Global Age-Related Macular Degeneration (AMD) Market, By Application, 2021
                2.1.3.    Global Age-Related Macular Degeneration (AMD) Market, By Geography, 2021

3.    Global Age-Related Macular Degeneration (AMD) Market Dynamics
        3.1.    Market Overview
        3.2.    Market Inclination Insights Analysis
        3.3.    Drivers
        3.4.    Challenges
        3.5.    Future Prospects
        3.6.    Impact Analysis of Drivers and Challenges During the Forecast Period, (2016-2026)
4. 	Age-Related Macular Degeneration (AMD) Market Overview
4.1	Product Overview and Scope of Pharmacy Automation Robot
4.2   Age-Related Macular Degeneration (AMD) Market Segmentation by Type
4.2.1 Global Production Market Share of Age-Related Macular Degeneration (AMD) by Type in 2022
	4.2.1 Type 1
	4.2.2 Type 2
	4.2.3 Type 3
4.3 Age-Related Macular Degeneration (AMD) Market Segmentation by Application
4.3.1 Age-Related Macular Degeneration (AMD) Consumption Market Share by Application in 2022
	4.3.2 Application 1
	4.3.3 Application 2
	4.3.4 Application 3
4.4 Age-Related Macular Degeneration (AMD) Market Segmentation by Regions
	4.4.1 North America
	4.4.2 Europe
	4.4.3 Asia Pacific
	4.4.4 Latin America
	4.4.5 Middle East & Africa
4.5 Global Market Size (Value) of Age-Related Macular Degeneration (AMD) (2022-2030)
5.   North America Age-Related Macular Degeneration (AMD) Market Analysis, 2022 – 2030
        5.1.    North America Age-Related Macular Degeneration (AMD) Market Size (US$), By Type, 2022 – 2030
        5.2.    North America Age-Related Macular Degeneration (AMD) Market Size (US$), By Application, 2022 – 2030
        5.3.    North America Age-Related Macular Degeneration (AMD) Market Size (US$), By End-use, 2022 – 2030
        5.4.    North America Age-Related Macular Degeneration (AMD) Market Size (US$), By Country, 2022 – 2030
                5.4.1.    U.S.
                5.4.2.    Canada
6.    Europe Age-Related Macular Degeneration (AMD) Market Analysis, 2022 – 2030
        6.1.    Europe Age-Related Macular Degeneration (AMD) Market Size (US$), By Type, 2022 – 2030
        6.2.    Europe Age-Related Macular Degeneration (AMD) Market Size (US$), By Application, 2022 – 2030
        6.3.    Europe Age-Related Macular Degeneration (AMD) Market Size (US$), By End-use, 2022 – 2030
        6.4.    Europe Age-Related Macular Degeneration (AMD) Market Size (US$), By Country, 2022 – 2030
                6.4.1.    U.K.
                6.4.2.    Germany
                6.4.3.    France
                6.4.4.    Rest of Europe
7.    Asia Pacific Age-Related Macular Degeneration (AMD) Market Analysis, 2022 – 2030
        7.1.    Asia Pacific Age-Related Macular Degeneration (AMD) Market Size (US$), By Type, 2022 – 2030
        7.2.    Asia Pacific Age-Related Macular Degeneration (AMD) Market Size (US$), By Application, 2022 – 2030
        7.3.    Asia Pacific Age-Related Macular Degeneration (AMD) Market Size (US$), By End-use, 2022 – 2030
        7.4.    Asia Pacific Age-Related Macular Degeneration (AMD) Market Size (US$), By Country, 2022 – 2030
                7.4.1.    China
                7.4.2.    Japan
                7.4.3.    India
                7.4.4.    Rest of Asia Pacific
8.    Latin America Age-Related Macular Degeneration (AMD) Market Analysis, 2022 – 2030
        8.1.    Latin America Age-Related Macular Degeneration (AMD) Market Size (US$), By Type, 2022 – 2030
        8.2.    Latin America Age-Related Macular Degeneration (AMD) Market Size (US$), By Application, 2022 – 2030
        8.3.    Latin America Age-Related Macular Degeneration (AMD) Market Size (US$), By End-use, 2022 – 2030
        8.4.    Latin America Age-Related Macular Degeneration (AMD) Market Size (US$), By Country, 2022 – 2030
                8.4.1.    Brazil
                8.4.2.    Mexico
                8.4.3.    Rest of Latin America
9.    Middle East & Africa (MEA) Age-Related Macular Degeneration (AMD) Market Analysis, 2022 – 2030
          9.1.     MEA Age-Related Macular Degeneration (AMD) Market Size (US$), By Type, 2022 – 2030
          9.2.    MEA Age-Related Macular Degeneration (AMD) Market Size (US$), By Application, 2022 – 2030
          9.3.    MEA Age-Related Macular Degeneration (AMD) Market Size (US$), By End-use, 2022 – 2030
          9.4.    MEA Age-Related Macular Degeneration (AMD) Market Size (US$), By Region, 2022 – 2030
                  9.4.1.    GCC Countries
                  9.4.2.    South Africa
                  9.4.3.    Rest of MEA
10.    Company Profiles
          12.1.    Competitive Analysis
          12.2.    Market Positioning of Key Vendors
          12.3.    Key Strategies adopted by the Leading Players
List of Tables
TABLE 1 Market Snapshot: Global Age-Related Macular Degeneration (AMD) Market 
TABLE 2 Impact Indicators
TABLE 3 Impact Analysis of Drivers and Restraints
TABLE 4 North America Age-Related Macular Degeneration (AMD) Market Revenue, By Type, 2022 – 2030 (US$ Mn)
TABLE 5 North America Age-Related Macular Degeneration (AMD) Market Revenue, By Application, 2022 – 2030 (US$ Mn)
TABLE 6 North America Age-Related Macular Degeneration (AMD) Market Revenue, By End-use, 2022 – 2030 (US$ Mn)
TABLE 7 Europe Age-Related Macular Degeneration (AMD) Market Revenue, By Type, 2022 – 2030 (US$ Mn)
TABLE 8 Europe Age-Related Macular Degeneration (AMD) Market Revenue, By Application, 2022 – 2030 (US$ Mn)
TABLE 9 Europe Age-Related Macular Degeneration (AMD) Market Revenue, By End-use, 2022 – 2030 (US$ Mn)
TABLE 10 Asia Pacific Age-Related Macular Degeneration (AMD) Market Revenue, By Type, 2022 – 2030 (US$ Mn)
TABLE 11 Asia Pacific Age-Related Macular Degeneration (AMD) Market Revenue, By Application, 2022 – 2030 (US$ Mn)
TABLE 12 Asia Pacific Age-Related Macular Degeneration (AMD) Market Revenue, By End-use, 2022 – 2030 (US$ Mn)
TABLE 13 Latin America Age-Related Macular Degeneration (AMD) Market Revenue, By Type, 2022 – 2030 (US$ Mn)
TABLE 14 Latin America Age-Related Macular Degeneration (AMD) Market Revenue, By Application, 2022 – 2030 (US$ Mn)
TABLE 15 Latin America Age-Related Macular Degeneration (AMD) Market Revenue, By End-use, 2022 – 2030 (US$ Mn)
TABLE 16 MEA Age-Related Macular Degeneration (AMD) Market Revenue, By Type, 2022 – 2030 (US$ Mn)
TABLE 17 MEA Age-Related Macular Degeneration (AMD) Market Revenue, By Application, 2022 – 2030 (US$ Mn)
TABLE 18 MEA Age-Related Macular Degeneration (AMD) Market Revenue, By End-use, 2022 – 2030 (US$ Mn)
        
List of Figures
FIG. 1 Global Age-Related Macular Degeneration (AMD) Market: Market Segmentation
FIG. 2 Global Age-Related Macular Degeneration (AMD) Market: Research Methodology
FIG. 3 Top-Down and Bottom-up Approach
FIG. 4 Global Age-Related Macular Degeneration (AMD) Market, By Type, 2021 (US$ Mn)
FIG. 5 Global Age-Related Macular Degeneration (AMD) Market, By Application, 2021 (US$ Mn)
FIG. 6 Global Age-Related Macular Degeneration (AMD) Market, By End-use, 2021 (US$ Mn)
FIG. 7 Global Age-Related Macular Degeneration (AMD) Market, By Geography, 2021 (US$ Mn)
FIG. 8 Global Age-Related Macular Degeneration (AMD) Market Revenue and Growth, 2022 – 2030, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition
FIG. 10 Market Positioning of Key Age-Related Macular Degeneration (AMD) Market Providers, 2021
FIG. 11 Global Age-Related Macular Degeneration (AMD) Market Revenue Contribution, By Type, 2022 & 2030(Value %)
FIG. 12 Global Age-Related Macular Degeneration (AMD) Market Revenue Contribution, By Application, 2022 & 2030(Value %)
FIG. 13 Global Age-Related Macular Degeneration (AMD) Market Revenue Contribution, By End-use, 2022 & 2030(Value %)
FIG. 14 North America Age-Related Macular Degeneration (AMD) Market Revenue, 2022 – 2030, (US$ Mn)
FIG. 15 Europe Age-Related Macular Degeneration (AMD) Market Revenue, 2022 – 2030, (US$ Mn)
FIG. 16 Asia Pacific Age-Related Macular Degeneration (AMD) Market Revenue, 2022 – 2030, (US$ Mn)
FIG. 17 Latin America Age-Related Macular Degeneration (AMD) Market Revenue, 2022 – 2030, (US$ Mn)
FIG. 18 MEA Age-Related Macular Degeneration (AMD) Market Revenue, 2022 – 2030, (US$ Mn)